Research graph
References from Global incidence of chronic lymphocytic leukemia: A systematic review and meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
10.1038/s41375-022-01620-2 · 2022 · External reference
Non-hodgkin's lymphoma: a review
10.4103/jfmpc.jfmpc_1037_19 · 2020 · External reference
Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification
10.1182/blood-2015-02-585059 · 2015 · External reference
Chronic lymphocytic leukaemia Australasian consensus practice statement
10.1111/imj.16207 · 2023 · External reference
A systematic review of economic evaluations for the pharmaceutical treatment of chronic lymphocytic leukemia and acute myeloid leukemia
10.1080/17474086.2022.2125376 · 2022 · External reference
Cancer survivors' long-term health service costs in Queensland, Australia: results of a population-level data linkage study (Cos-Q)
10.3390/ijerph19159473 · 2022 · External reference
Unresolved reference
2023 · External reference
Incidence, prevalence, survival and mortality of chronic lymphocytic leukaemia/small lymphocytic lymphoma and waldenström macroglobulinaemia in Australia
10.1002/cam4.71582 · 2026 · External reference
National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953–2012: a systematic analysis of population-based data
10.1002/cam4.849 · 2016 · External reference
Trends in adult leukemia incidence and survival in Denmark, 1943-2003
2009 · External reference
Global burden of hematologic malignancies and evolution patterns over the past 30 years
10.1038/s41408-023-00853-3 · 2023 · External reference
The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019
10.1186/s12938-021-00973-6 · 2022 · External reference
Trends in disease burden of chronic lymphocytic leukemia at the global, regional, and national levels from 1990 to 2019, and projections until 2030: a population-based epidemiologic study
10.3389/fonc.2022.840616 · 2022 · External reference
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · External reference
Delivering affordable cancer care in high-income countries
10.1016/s1470-2045(11)70141-3 · 2011 · External reference
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy
2014 · External reference
Unresolved reference
2020 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · 2021 · External reference
Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdv303 · 2015 · External reference
Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
10.1002/ajh.26367 · 2021 · External reference
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
2018 · External reference
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 · External reference
10.1182/blood.v87.12.4990.bloodjournal87124990
10.1182/blood.v87.12.4990.bloodjournal87124990 · External reference
The incidence of pediatric ischemic stroke: a systematic review and meta-analysis
10.1177/17474930231155336 · 2023 · External reference
L G. Examination of pediatric hemorrhagic stroke incidence: a systematic review and meta-analysis
2025 · External reference
Unresolved reference
External reference
Unresolved reference
2000 · External reference
Unresolved reference
External reference
A Systematic review and meta-analysis of the incidence rate of takayasu arteritis
2020 · External reference
A basic introduction to fixed-effect and random-effects models for meta-analysis
10.1002/jrsm.12 · 2010 · External reference
Quantifying heterogeneity in a meta-analysis
10.1002/sim.1186 · 2002 · External reference
Unresolved reference
2022 · External reference
An extended mixed-effects framework for meta-analysis
10.1002/sim.8362 · 2019 · External reference
Methods to estimate the between-study variance and its uncertainty in meta-analysis
10.1002/jrsm.1164 · 2016 · External reference
The application of meta-analytic (multi-level) models with multiple random effects: a systematic review
10.3758/s13428-020-01373-9 · 2020 · External reference
Measuring inconsistency in meta-analyses
2003 · External reference
Complex relationships between diagnostics and survival in chronic lymphocytic leukemia in Denmark, Finland, Norway, and Sweden
10.3390/cancers16183229 · 2024 · External reference
Global burden of chronic lymphocytic leukemia from 1990 to 2021
10.1177/10732748251397071 · 2025 · External reference
Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data
10.1002/1097-0142(20010901)92:5<1325::aid-cncr1454>3.0.co;2-e · 2001 · External reference
Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada
10.1016/j.leukres.2015.01.015 · 2015 · External reference
Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999–2010: comparison to plasma cell myeloma
10.3109/10428194.2015.1068307 · 2016 · External reference
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy
10.1002/hon.826 · 2007 · External reference
Leukemia epidemiology and burden of disease in South Africa: 2015–2019
10.1016/j.canep.2025.102818 · 2025 · External reference
Unveiling the burden of leukemia in Eritrea (2010-2020): chronic leukemia stability, rising ALL incidence, and the enigma of CML in a low-resource setting
2025 · External reference
Unresolved reference
2017 · External reference
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
10.1002/cyto.b.21595 · 2018 · External reference
Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data
10.1002/1097-0142(20010901)92:5<1325::aid-cncr1454>3.0.co;2-e · ExternalCitation · doi-reference
Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
10.1002/ajh.26367 · ExternalCitation · doi-reference
Incidence, prevalence, survival and mortality of chronic lymphocytic leukaemia/small lymphocytic lymphoma and waldenström macroglobulinaemia in Australia
10.1002/cam4.71582 · ExternalCitation · doi-reference
National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953–2012: a systematic analysis of population-based data
10.1002/cam4.849 · ExternalCitation · doi-reference
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
10.1002/cyto.b.21595 · ExternalCitation · doi-reference
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy
10.1002/hon.826 · ExternalCitation · doi-reference
Methods to estimate the between-study variance and its uncertainty in meta-analysis
10.1002/jrsm.1164 · ExternalCitation · doi-reference
A basic introduction to fixed-effect and random-effects models for meta-analysis
10.1002/jrsm.12 · ExternalCitation · doi-reference
Quantifying heterogeneity in a meta-analysis
10.1002/sim.1186 · ExternalCitation · doi-reference
An extended mixed-effects framework for meta-analysis
10.1002/sim.8362 · ExternalCitation · doi-reference
Leukemia epidemiology and burden of disease in South Africa: 2015–2019
10.1016/j.canep.2025.102818 · ExternalCitation · doi-reference
Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada
10.1016/j.leukres.2015.01.015 · ExternalCitation · doi-reference
Delivering affordable cancer care in high-income countries
10.1016/s1470-2045(11)70141-3 · ExternalCitation · doi-reference
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
10.1038/s41375-022-01620-2 · ExternalCitation · doi-reference
Global burden of hematologic malignancies and evolution patterns over the past 30 years
10.1038/s41408-023-00853-3 · ExternalCitation · doi-reference
A systematic review of economic evaluations for the pharmaceutical treatment of chronic lymphocytic leukemia and acute myeloid leukemia
10.1080/17474086.2022.2125376 · ExternalCitation · doi-reference
Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdv303 · ExternalCitation · doi-reference
Chronic lymphocytic leukaemia Australasian consensus practice statement
10.1111/imj.16207 · ExternalCitation · doi-reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · ExternalCitation · doi-reference
Global burden of chronic lymphocytic leukemia from 1990 to 2021
10.1177/10732748251397071 · ExternalCitation · doi-reference
The incidence of pediatric ischemic stroke: a systematic review and meta-analysis
10.1177/17474930231155336 · ExternalCitation · doi-reference
Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification
10.1182/blood-2015-02-585059 · ExternalCitation · doi-reference
10.1182/blood.v87.12.4990.bloodjournal87124990
10.1182/blood.v87.12.4990.bloodjournal87124990 · ExternalCitation · doi-reference
The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019
10.1186/s12938-021-00973-6 · ExternalCitation · doi-reference
Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999–2010: comparison to plasma cell myeloma
10.3109/10428194.2015.1068307 · ExternalCitation · doi-reference
Trends in disease burden of chronic lymphocytic leukemia at the global, regional, and national levels from 1990 to 2019, and projections until 2030: a population-based epidemiologic study
10.3389/fonc.2022.840616 · ExternalCitation · doi-reference
Complex relationships between diagnostics and survival in chronic lymphocytic leukemia in Denmark, Finland, Norway, and Sweden
10.3390/cancers16183229 · ExternalCitation · doi-reference
Cancer survivors' long-term health service costs in Queensland, Australia: results of a population-level data linkage study (Cos-Q)
10.3390/ijerph19159473 · ExternalCitation · doi-reference
The application of meta-analytic (multi-level) models with multiple random effects: a systematic review
10.3758/s13428-020-01373-9 · ExternalCitation · doi-reference
Non-hodgkin's lymphoma: a review
10.4103/jfmpc.jfmpc_1037_19 · ExternalCitation · doi-reference
